Wayland, MA, United States of America

Paul F Schendel


Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 156(Granted Patents)


Company Filing History:


Years Active: 1991-2005

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Paul F. Schendel: Innovator in Therapeutic Applications

Introduction

Paul F. Schendel, based in Wayland, Massachusetts, is an accomplished inventor known for his significant contributions in the field of therapeutic innovations. With a portfolio of 12 patents, his work primarily focuses on utilizing Interleukin-11 in treating various medical conditions, particularly inflammatory diseases.

Latest Patents

Among his latest patents, Paul has developed a method of using Interleukin-11 for treating mucositis. This invention provides topical formulations aimed at addressing a variety of disorders, including several types of inflammatory bowel diseases, mucositis in different forms, necrotizing enterocolitis, and various inflammatory skin disorders. Additionally, he has patented a method specifically for treating inflammatory bowel disease using a topical formulation of IL-11, showcasing the versatility and impact of his research.

Career Highlights

Throughout his career, Paul has been associated with Genetics Institute, Inc., where he contributed to advancing the understanding and treatment of inflammatory conditions. His inventive work has positioned him as a valuable figure in the medical research community, with a focus on developing practical applications for complex health issues.

Collaborations

Paul F. Schendel has collaborated with notable individuals such as James Keith and Camille L. Bedrosian. These partnerships have likely fostered innovation and creativity in his projects, supporting his endeavors in developing effective therapeutic formulations.

Conclusion

Paul F. Schendel's dedication to research and innovation has resulted in significant advancements in treatments for inflammatory diseases. His patented methods utilizing Interleukin-11 demonstrate his commitment to improving patient care through innovative therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…